Mechanistic mathematical modelling of mercaptopurine effects on cell cycle of human acute lymphoblastic leukaemia cells

Por Panetta, J C, Evans, W E, Cheok, M H
Publicado em 2006

Pharmacogenetic Pathway Analysis of Irinotecan

Por Rosner, G. L., Panetta, J. C., Innocenti, F., Ratain, M. J.
Publicado em 2008

Comparison of native E. coli and PEG asparaginase pharmacokinetics and pharmacodynamics in pediatric acute lymphoblastic leukemia

Por Panetta, J.C., Gajjar, A., Hijiya, N., Hak, L.J., Cheng, C., Liu, W., Pui, C.H., Relling, M.V.
Publicado em 2009

The effect of body mass index at diagnosis on clinical outcome in children with newly diagnosed acute lymphoblastic leukemia

Por Eissa, H M, Zhou, Y, Panetta, J C, Browne, E K, Jeha, S, Cheng, C, Relling, M V, Campana, D, Pui, C-H, Inaba, H
Publicado no Blood Cancer J (2017)

Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation

Por Mohanan, E, Panetta, J C, Lakshmi, K M, Edison, E S, Korula, A, Fouzia, N A, Abraham, A, Viswabandya, A, Mathews, V, George, B, Srivastava, A, Balasubramanian, P
Publicado no Bone Marrow Transplant (2017)

Successful challenges using native E. coli asparaginase after hypersensitivity reactions to PEGylated E. coli asparaginase

Por Fernandez, C.A., Stewart, E., Panetta, J.C., Wilkinson, M.R., Morrison, A.R., Finkelman, F.D., Sandlund, J.T., Pui, C.H, Jeha, S., Relling, M.V., Campbell, P.K.
Publicado em 2014